Vivaglobin
STN: 125115
Proper Name: Immune Globulin Subcutaneous (Human)
Tradename: Vivaglobin
Manufacturer: CSL Behring GmbH, License #1765
Indication:
- Treatment of patients with primary immune deficiency (PID)
On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.